Nanologica’s SVP Sales and Senior Advisor for Chromatography, Mr. PK Dutta, PhD in a discussion with CEO Andreas Bhagwani regarding his new appointment and his view on the peptide/preparative chromatography market: Watch the interview
Latest News & PR
The number of shares in Nanologica AB (publ) has changed during the month of February as a result of options from the stock option program 2018/21 being exercised. A share-based incentive program of a maximum of 483 883 options was decided by the Annual General Meeting May 31, 2018. The program expires July 1st, 2021
Nanologica is a public company listed for trade on Spotlight Stock Market. For information regarding financial reports, press releases, presentations and share holder information, please visit our investor relations section.
Presentation of Nanologica
Company presentation made by CEO Andreas Bhagwani on May 28, 2019.
For more videos about the Company as well as video presentations of interim reports, please refer to Investor Relations.